NCT05532033

Brief Summary

Prospective randomized study investigating the effect of postoperative oxygen delivery on diaphragmatic function. Two different modalities of oxygen delivery will be compared: high flow nasal cannula versus standard oxygen therapy with facial mask

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

August 9, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 8, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2023

Completed
Last Updated

October 24, 2023

Status Verified

October 1, 2023

Enrollment Period

1.2 years

First QC Date

August 9, 2022

Last Update Submit

October 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of diaphragmatic dysfunction

    Ultrasound evaluation of diaphragmatic dysfunction

    24 hours after surgery

Secondary Outcomes (1)

  • Postoperative pulmonary complication

    7 days after surgery

Other Outcomes (1)

  • Days without oxygen support

    7 days

Study Arms (2)

high flow nasal cannula

EXPERIMENTAL

Two hours after extubation patients will received high flow nasal cannula oxygenation therapy for 24 hours

Device: High flow nasal cannula

Standard oxygen therapy

ACTIVE COMPARATOR

Two hours after extubation patients will received standard oxygenation therapy for 24 hours

Device: Facial mask

Interventions

A device able to delivery high flow oxygen therapy

high flow nasal cannula

standard oxygen therapy

Standard oxygen therapy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for elective thoracic surgery

You may not qualify if:

  • ASA score \>3
  • Body mass index \> 35 kg/m2
  • History of neuromuscular disease
  • History of thoracic surgery
  • Phrenic nerve paisy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Università di Ferrara

Ferrara, 44121, Italy

Location

Related Publications (1)

  • Fogagnolo A, Grasso S, Dres M, Azzolina D, Dalla Corte F, Dolci G, Tamburini N, De Paoli G, Murgolo F, Pedarzani E, Andalo A, Volta CA, Savino S. Impact of early high flow nasal oxygen on diaphragmatic function and pulmonary complications after thoracic surgery: A randomized clinical trial. J Clin Anesth. 2025 Sep;106:111945. doi: 10.1016/j.jclinane.2025.111945. Epub 2025 Jul 23.

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 9, 2022

First Posted

September 8, 2022

Study Start

August 9, 2022

Primary Completion

October 15, 2023

Study Completion

October 22, 2023

Last Updated

October 24, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Study dataset will be shared in anonymous form under reasonable request

Shared Documents
STUDY PROTOCOL, SAP

Locations